Alexandros Athanasiou

Alexandros Athanasiou has over 16 years of experience in the pharmaceutical industry, with a significant tenure at Takeda from September 2011 to April 2024, where roles included Head of Marketing Innovation & Excellence for the Japan Oncology Business Unit, Europe & Canada Brand Lead for the Lung franchise, and Marketing Lead for Oncology in the Balkans and South Eastern Europe. Notably, Alexandros led the successful launch of ALUNBRIG during the global pandemic, achieving remarkable double-digit growth in the EUCan region. Prior to Takeda, experience included sales representative positions at Nycomed Hellas and DEMO Pharmaceuticals S.A. Academically, Alexandros holds a Doctor of Science in Business Administration and Management from the Swiss School of Business and Management, as well as an MBA from the Hellenic Management Association.